The global organoids market is expected to grow at a CAGR of 16.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of chronic diseases and rising demand for personalized medicine.
Intestinal Organoid: Intestinal organoids are used in research and development of drugs for gastrointestinal disorders such as inflammatory bowel disease, Crohn's disease, ulcerative colitis, celiac disease, and irritable bowel syndrome. The intestinal organoid segment accounted for the largest share in the global market in 2018 owing to its wide application across various therapeutic areas.
Hepatic Organoid: Hepatic organoids are used in research and development of drugs for liver diseases such as hepatitis B virus infection (HBV), hepatitis C virus infection (HCV), nonalcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD) and cirrhosis. The hepatic organoid segment accounted for the second-largest share in the global market in 2018 owing to its wide application across various therapeutic areas.
Pancreatic Organoid: Pancreatic organoids are used in research and development of drugs for pancreatic diseases such as pancreatitis, diabetes mellitus type 1 & 2, cystic fibrosis-related diabetes mellitus type 1 & 2, pancreatic cancer and pancreatitis-associated diabetes mellitus type 1 & 2.The pancreatic organoid segment accounted for the third-largest share in the global market in 2018 owing to its wide application across various therapeutic areas.
Some Of The Growth Factors Of This Market:
- Organoids are used in drug discovery and development, as well as in the study of human diseases and disorders.
- Organoids are also used to test the safety and efficacy of new drugs before they are tested on humans, which reduces the risk of side effects or other complications that may arise during clinical trials with humans.
- Organoid technology has been shown to be more accurate than animal models when it comes to predicting how a drug will behave in humans.
Industry Growth Insights published a new data on “Organoids Market”. The research report is titled “Organoids Market research by Types (Intestinal Organoid, Hepatic Organoid, Pancreatic Organoid, Neural Organoid, Others), By Applications (Biopharmaceutical Companies, Contract Research Organizations, Academics and Research Institutes), By Players/Companies STEMCELL Technologies, Hubrecht Organoid Technology(HUB, Cellesce, Qgel, DefiniGEN, OcellO BV”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Organoids Market Research Report
By Type
Intestinal Organoid, Hepatic Organoid, Pancreatic Organoid, Neural Organoid, Others
By Application
Biopharmaceutical Companies, Contract Research Organizations, Academics and Research Institutes
By Companies
STEMCELL Technologies, Hubrecht Organoid Technology(HUB, Cellesce, Qgel, DefiniGEN, OcellO BV
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Organoids Market Report Segments:
The global Organoids market is segmented on the basis of:
Types
Intestinal Organoid, Hepatic Organoid, Pancreatic Organoid, Neural Organoid, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biopharmaceutical Companies, Contract Research Organizations, Academics and Research Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- STEMCELL Technologies
- Hubrecht Organoid Technology(HUB
- Cellesce
- Qgel
- DefiniGEN
- OcellO BV
Highlights of The Organoids Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Intestinal Organoid
- Hepatic Organoid
- Pancreatic Organoid
- Neural Organoid
- Others
- By Application:
- Biopharmaceutical Companies
- Contract Research Organizations
- Academics and Research Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Organoids Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Organoids are miniature versions of organs or tissues that have been grown in a laboratory. They can be used to study how cells interact and function in the body, and they may also be used to develop new treatments for diseases.
Some of the major players in the organoids market are STEMCELL Technologies, Hubrecht Organoid Technology(HUB, Cellesce, Qgel, DefiniGEN, OcellO BV.
The organoids market is expected to grow at a compound annual growth rate of 16.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Organoids Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Organoids Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Organoids Market - Supply Chain
4.5. Global Organoids Market Forecast
4.5.1. Organoids Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Organoids Market Size (000 Units) and Y-o-Y Growth
4.5.3. Organoids Market Absolute $ Opportunity
5. Global Organoids Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Organoids Market Size and Volume Forecast by Type
5.3.1. Intestinal Organoid
5.3.2. Hepatic Organoid
5.3.3. Pancreatic Organoid
5.3.4. Neural Organoid
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Organoids Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Organoids Market Size and Volume Forecast by Application
6.3.1. Biopharmaceutical Companies
6.3.2. Contract Research Organizations
6.3.3. Academics and Research Institutes
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Organoids Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Organoids Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Organoids Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Organoids Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Organoids Demand Share Forecast, 2019-2026
9. North America Organoids Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Organoids Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Organoids Market Size and Volume Forecast by Application
9.4.1. Biopharmaceutical Companies
9.4.2. Contract Research Organizations
9.4.3. Academics and Research Institutes
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Organoids Market Size and Volume Forecast by Type
9.7.1. Intestinal Organoid
9.7.2. Hepatic Organoid
9.7.3. Pancreatic Organoid
9.7.4. Neural Organoid
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Organoids Demand Share Forecast, 2019-2026
10. Latin America Organoids Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Organoids Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Organoids Market Size and Volume Forecast by Application
10.4.1. Biopharmaceutical Companies
10.4.2. Contract Research Organizations
10.4.3. Academics and Research Institutes
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Organoids Market Size and Volume Forecast by Type
10.7.1. Intestinal Organoid
10.7.2. Hepatic Organoid
10.7.3. Pancreatic Organoid
10.7.4. Neural Organoid
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Organoids Demand Share Forecast, 2019-2026
11. Europe Organoids Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Organoids Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Organoids Market Size and Volume Forecast by Application
11.4.1. Biopharmaceutical Companies
11.4.2. Contract Research Organizations
11.4.3. Academics and Research Institutes
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Organoids Market Size and Volume Forecast by Type
11.7.1. Intestinal Organoid
11.7.2. Hepatic Organoid
11.7.3. Pancreatic Organoid
11.7.4. Neural Organoid
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis byType
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Organoids Demand Share, 2019-2026
12. Asia Pacific Organoids Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Organoids Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Organoids Market Size and Volume Forecast by Application
12.4.1. Biopharmaceutical Companies
12.4.2. Contract Research Organizations
12.4.3. Academics and Research Institutes
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Organoids Market Size and Volume Forecast by Type
12.7.1. Intestinal Organoid
12.7.2. Hepatic Organoid
12.7.3. Pancreatic Organoid
12.7.4. Neural Organoid
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Organoids Demand Share, 2019-2026
13. Middle East & Africa Organoids Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Organoids Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Organoids Market Size and Volume Forecast by Application
13.4.1. Biopharmaceutical Companies
13.4.2. Contract Research Organizations
13.4.3. Academics and Research Institutes
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Organoids Market Size and Volume Forecast by Type
13.7.1. Intestinal Organoid
13.7.2. Hepatic Organoid
13.7.3. Pancreatic Organoid
13.7.4. Neural Organoid
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Organoids Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Organoids Market: Market Share Analysis
14.2. Organoids Distributors and Customers
14.3. Organoids Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. STEMCELL Technologies
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Hubrecht Organoid Technology(HUB
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Cellesce
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Qgel
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. DefiniGEN
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. OcellO BV
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
